WHO’s 2026 Fluid Management Guideline for Acutely Ill Children: What Clinicians Need to Know.
Fluid therapy is one of the most familiar interventions in paediatric practice. That familiarity can make it easy to forget an important principle:
IV fluid is a treatment and like any treatment, it has indications, benefits and potential harms.
The World Health Organization (WHO) has published its 2026 guideline on fluid management of acutely ill children, providing evidence-based recommendations for children aged 2 months to 12 years. The guidance covers fluid and blood management in acute illness, including children with shock, anaemia and wasting or nutritional oedema - which is particularly relevant in global child health.
For clinicians working in the UK, many of the principles will feel familiar, and it's important to follow established UK pathways or local policies.
However, the guideline provides a useful opportunity to revisit how we think about fluid therapy in sick children.
The overarching message: fluids aren't benign
Perhaps the most useful message isn't a new calculation or another algorithm.
It is the shift away from thinking:
“This child is unwell — do they need some fluid?”
towards a more deliberate series of questions:
Why am I giving fluid?
Which route is appropriate?
What fluid does this child need?
How much?
How quickly?
And what happened after I gave it?
The WHO guideline reinforces a more considered approach to fluid prescribing and administration, particularly in acutely ill children.
1. Use the enteral route when possible
One of the practical principles is straightforward: IV isn't automatically better.
Where clinically appropriate and tolerated, oral or enteral fluid should be used rather than moving unnecessarily to intravenous therapy. That sounds basic, but it challenges an easy assumption in acute care that escalation of illness automatically means escalation to IV fluid. The route should be determined by the child's clinical condition and the purpose of the fluid therapy.
2. A child who is unwell is not necessarily a child who needs a fluid bolus
This is probably one of the most important messages for clinicians.
Tachycardia alone does not equal shock. Acutely unwell children can be tachycardic for many reasons:
Fever
Pain
Anxiety or distress
Dehydration
Medication
Hypoxia
Sepsis
Impaired circulation
Fluid boluses should therefore not become an automatic response to an abnormal heart rate or to a child simply appearing unwell. The distinction between shock and other evidence of illness or circulatory disturbance matters. Earlier WHO guidance was already influenced by evidence showing potential harm from indiscriminate fluid bolus therapy in some critically ill children. The updated work continues the focus on identifying which children actually require rapid intravascular volume expansion rather than assuming that more fluid is inherently beneficial. For practice, the important question becomes: What evidence do I have that this child requires fluid resuscitation? That means assessing the whole child: mental state, peripheral perfusion, pulse quality, capillary refill, blood pressure where appropriate, urine output, respiratory status and the trajectory of their observations.
3. Maintenance fluid deserves just as much thought as resuscitation fluid
Fluid safety isn't only about boluses. Children requiring IV maintenance therapy are also vulnerable to complications from inappropriate fluid composition or volume. One of the clearer evidence-based messages highlighted alongside the new guideline is the use of isotonic rather than hypotonic solutions for maintenance fluid therapy, supported by high-certainty evidence.
This matters because hospitalised children can have increased antidiuretic hormone secretion in response to illness, pain, nausea, stress and surgery. Giving excessive electrolyte-free water in that context can contribute to hospital-acquired hyponatraemia. For clinicians administering or prescribing maintenance fluids, don't just ask: “What is their maintenance rate?”
Also ask: Does this child need the full calculated maintenance volume? What is in the fluid? What other fluid are they receiving? What are their electrolytes doing?
A perfectly calculated rate can still be the wrong prescription for the child in front of you.
4. Think beyond volume
When we talk about fluids, discussion can become dominated by mL/kg. But safe fluid therapy requires more than calculating a volume. Consider:
Route – does this actually need to be IV?
Composition – which fluid is appropriate?
Volume – how much does this child require?
Rate – how quickly should it be given?
Glucose – does this child require glucose-containing fluid or additional glucose management?
Electrolytes – what is happening to sodium, potassium and the wider biochemical picture?
Ongoing losses – are these being measured and replaced appropriately?
Comorbidities – does this child have a condition that changes their ability to tolerate fluid?
The prescription should reflect the child's physiology and clinical condition rather than simply applying a formula.
5. Reassessment is part of the treatment
This is perhaps the point most worth taking back into everyday practice. Giving fluid isn't the end of the intervention. If fluid is given because you believe a child has impaired circulation, you should know what improvement you expect to see. Then look for it.
Has their:
Heart rate changed?
Capillary refill improved?
Pulse quality improved?
Mental state changed?
Urine output improved?
Blood pressure changed?
Respiratory status deteriorated?
And crucially:
Is there evidence of fluid overload?
The response to treatment provides new clinical information.
If the expected response isn't happening, the answer should not automatically be more fluid.
Stop. Reassess. Reconsider the physiology and escalate appropriately. So, does this change UK practice? For many UK clinicians, the answer is: Not dramatically and that is worth saying clearly. Many of these principles are already embedded within contemporary paediatric practice: careful assessment before fluid resuscitation, isotonic maintenance fluids, enteral rehydration where appropriate and repeated reassessment. The WHO guideline should also not be presented as replacing NICE guidance, national UK recommendations or local organisational pathways.
WHO produces global normative guidance intended to help countries develop national policies, protocols and clinical tools. WHO specifically describes these recommendations as informing national programmes and future clinical tools for the management of acutely ill children.
UK clinicians should therefore continue to work within their relevant NICE, national and local guidance. The value of the WHO publication is different. It provides an opportunity to examine the evidence underpinning something we do extremely frequently and ask whether our everyday practice reflects the principles of safe fluid management.
What should clinicians take into practice?
The message isn't “give less fluid.”
The better message is: Give the right fluid, to the right child, for the right reason, by the right route and at the right rate — then reassess. Before starting fluid therapy in an acutely ill child, be clear about what you are treating. Before giving a bolus, establish why you believe the child requires fluid resuscitation. When prescribing maintenance fluid, think beyond the mathematical calculation. And after giving fluid, actively assess whether the intervention achieved what you intended. Because IV fluids may be commonplace in paediatric care. But commonplace does not mean harmless.
Reflection for practice
Think about the last acutely unwell child you cared for who received IV fluids.
Could you clearly identify:
Why the fluid was being given?
What physiological response you expected?
What changed after it was administered?
And if nothing changed, what did you do next?
That is the difference between administering fluid and actively managing fluid therapy.
Further reading
World Health Organization. WHO guideline on fluid management of acutely ill children. Geneva: WHO; 2026.
The guideline is intended for healthcare professionals and those developing policies and programmes for the management of acutely ill children aged 2 months to 12 years.
Saffron Health Education
Practical, clinician-led CPD that helps healthcare professionals translate knowledge into clinical decisions.
Recognise. Interpret. Act. Reflect.
Comments